PMID- 29669717
OWN - NLM
STAT- MEDLINE
DCOM- 20181211
LR  - 20181211
IS  - 1756-1833 (Electronic)
IS  - 0959-8138 (Linking)
VI  - 361
DP  - 2018 Apr 18
TI  - Weighing the risks of valproate in women who could become pregnant.
PG  - k1596
LID - 10.1136/bmj.k1596 [doi]
FAU - Angus-Leppan, Heather
AU  - Angus-Leppan H
AD  - Epilepsy Initiative Group, Royal Free London, London, UK
      heather.angus-leppan@nhs.net.
AD  - University College London.
AD  - Centre for Research in Public Health and Community Care, University of
      Hertfordshire.
FAU - Liu, Rebecca S N
AU  - Liu RSN
AD  - Epilepsy Initiative Group, Royal Free London, London, UK.
LA  - eng
PT  - Journal Article
DEP - 20180418
PL  - England
TA  - BMJ
JT  - BMJ (Clinical research ed.)
JID - 8900488
RN  - 0 (Anticonvulsants)
RN  - 614OI1Z5WI (Valproic Acid)
SB  - AIM
SB  - IM
MH  - Abnormalities, Drug-Induced/epidemiology/*etiology
MH  - Anticonvulsants/*adverse effects/therapeutic use
MH  - Contraindications, Drug
MH  - Developmental Disabilities/chemically induced/epidemiology
MH  - Epilepsy/*drug therapy/epidemiology
MH  - Female
MH  - Humans
MH  - Informed Consent
MH  - Patient Safety
MH  - Pregnancy
MH  - Pregnancy Complications/*drug therapy/epidemiology
MH  - Prenatal Exposure Delayed Effects
MH  - Risk Assessment/methods
MH  - Valproic Acid/*adverse effects/therapeutic use
COIS- Competing interests: We have read and understood BMJ policy on declaration of
      interests and have no relevant interests to declare.
EDAT- 2018/04/20 06:00
MHDA- 2018/12/12 06:00
CRDT- 2018/04/20 06:00
PHST- 2018/04/20 06:00 [entrez]
PHST- 2018/04/20 06:00 [pubmed]
PHST- 2018/12/12 06:00 [medline]
AID - 10.1136/bmj.k1596 [doi]
PST - epublish
SO  - BMJ. 2018 Apr 18;361:k1596. doi: 10.1136/bmj.k1596.